Perspectives of HER2-targeting in gastric and esophageal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Perspectives of HER2-targeting in gastric and esophageal cancer

Published:2017-04-24 Issue:5 Volume:26 Page:531-540
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Gerson James N¹,Skariah Sam²,Denlinger Crystal S.¹,Astsaturov Igor³

Affiliation:

1. Department of Hemagology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA

2. Abington Memorial Hospital, Abington, PA, USA

3. Program in Molecular Therapeutics and Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA

Funder

National Cancer Institute

Russian Science Foundation

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2017.1315406

Reference95 articles.

1. Neural expression and chromosomal mapping of Neu differentiation factor to 8p12-p21.

2. ErbB2 is essential in the prevention of dilated cardiomyopathy

3. Insights into ErbB signaling from the structure of the ErbB2-pertuzumab complex

4. The Crystal Structure of a Truncated ErbB2 Ectodomain Reveals an Active Conformation, Poised to Interact with Other ErbB Receptors

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthetic routes and clinical application of Small-Molecule HER2 inhibitors for cancer therapy;Bioorganic Chemistry;2024-10

2. Immune Checkpoint Inhibitors in Esophageal Carcinoma;Surgical Oncology Clinics of North America;2024-07

3. Therapeutic implications of signaling pathways and tumor microenvironment interactions in esophageal cancer;Biomedicine & Pharmacotherapy;2024-07

4. Drug Delivery Opportunities in Esophageal Cancer: Current Treatments and Future Prospects;Molecular Pharmaceutics;2024-06-18

5. Advances in targeted therapy for human epidermal growth factor receptor 2 positive in advanced gastric cancer;World Journal of Gastrointestinal Oncology;2024-06-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3